T65.844S is a new billable/specific and POA-exempt diagnosis code introduced in the 2026 ICD-10-CM used to classify the following condition: Toxic effect of xylazine, undetermined, sequela.
Versions
2026
New code
T65.844S is a new billable/specific and POA-exempt diagnosis code introduced in the 2026 ICD-10-CM used to classify the following condition: Toxic effect of xylazine, undetermined, sequela.
New code